Codiak Appoints David Mauro, M.D., Ph.D., as Chief Medical Officer
– Experienced oncology drug developer with more than two decades advancing treatments for solid tumors and hematologic malignancies joins Codiak leadership...
News
F-star Therapeutics to Announce First Quarter Results and Host Conference Call on Tuesday, May 10th, 2022
CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., May 02, 2022 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company...
Sorrento Announces Full Enrollment of Phase I Study of Intranasal STI-9199 (COVISHIELD™ IN), a Potent Neutralization Antibody Against Omicron BA.2 and All Variants of Concern
The Phase I safety and pharmacokinetic study in 24 healthy volunteers has completed enrollment. The study is still blinded, but...
Harpoon Therapeutics and Roche to Collaborate on Clinical Trials to Study Novel Immuno-Oncology Combination for Small Cell Lung Cancer
HPN328, Harpoon’s DLL3-targeting T cell engager, to be evaluated in combination with anti-PD-L1 antibody in patients with small cell lung...
Digipath Validates and Receives Approval to Use Free DNA Removal to Test for Aspergillus
LAS VEGAS, NV, May 02, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Digipath, Inc. (OTCQB: DIGP) (“Digipath” or the “Company”),...
Dr Catherine Song Opens New Cosmetic Dentist Practice in Beverly Hills
Beverly Hills, May 02, 2022 (GLOBE NEWSWIRE) -- While studying for her Doctor of Dental Surgery degree at the University...
CohBar to Announce 2022 First Quarter Financial Results and Provide Business Update on May 16, 2022
Company to host conference call and webcast at 5:00 p.m. ETMENLO PARK, Calif., May 02, 2022 (GLOBE NEWSWIRE) -- CohBar,...
BrainsWay Launches #DontMissAnotherMoment Social Media Campaign to Promote Mental Health Awareness Month
BrainsWay will donate $5 per share, $2 per comment, and $1 per like to support the work of Mental Health AmericaBURLINGTON,...
Sun Sentinel Names Accelus a Winner of the South Florida Top Workplaces 2022 Award
Leading medical technology company recognized for employee engagement and culturePALM BEACH GARDENS, Fla., May 02, 2022 (GLOBE NEWSWIRE) -- Accelus,...
SciSparc Files Annual Report for Year Ended December 31, 2021 and Provides Corporate Update
TEL AVIV, Israel, May 02, 2022 (GLOBE NEWSWIRE) -- SciSparc Ltd. (NASDAQ: SPRC), a specialty clinical-stage pharmaceutical company focusing on...
Palisade Bio Provides Business Outlook and Highlights Expected Near-Term Pipeline Advancements
Phase 3 study of LB1148 in lead indication for postoperative return of bowel function on track to commence Q2 2022CARLSBAD, Calif.,...
Healthy Extracts’ First Major Brand Influencer Launches New Line of Natural Health and Fitness Formulations on WhitneyJohns.com
Whitney Johns Product Line The New Whitney Johns Product Line includes BRAIN ACTIVATE (in gel and powder form), ACTIVE for...
Alaunos Therapeutics Doses First Patient in TCR-T Library Phase 1/2 trial for the Treatment of Patients with Solid Tumors
First-in-human non-viral TCR-T cell therapy targeting shared hotspot mutations in solid cancersFirst clinical product manufactured and administered to a patient...
Silk Road Medical Announces FDA Approval of Expanded Indications for the ENROUTE® Transcarotid Stent System
SUNNYVALE, Calif., May 02, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk...
FDA Has Granted Veru a Pre-Emergency Use Authorization (EUA) Meeting Date for Positive Sabizabulin Phase 3 COVID-19 Study
MIAMI, May 02, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company, today announced that the FDA has...
Denali Therapeutics Announces Achievement of RIPK1 Milestone for Phase 2 Clinical Trial Initiation in ALS by Sanofi
Partner Sanofi has commenced dosing in a Phase 2 clinical trial of SAR443820 (DNL788) in individuals with amyotrophic lateral sclerosis...
Galecto to Participate at Upcoming Investor Conferences
BOSTON, May 02, 2022 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical stage biotechnology company focused on the development...
NKGen Biotech Announces Three SNK01 Abstracts to be Presented at the 2022 ASCO Annual Meeting
SANTA ANA, Calif., May 02, 2022 (GLOBE NEWSWIRE) -- NKGen Biotech Inc., a biotechnology company harnessing the power of the...
Treace Secures Up to $150 Million in Debt Financing
PONTE VEDRA, Fla., May 02, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (Nasdaq: TMCI), a...
TFF Pharmaceuticals Announces Multiple Presentations Highlighting Broad Applicability of its Thin Film Freezing Technology at Respiratory Drug Delivery Meeting (RDD)
Thin Film Freezing Technology Co-Inventor Dr. Robert O. Williams III to Deliver Platform Presentation of Data on Stabilizing and Delivering...
